The WATSON project (2017–2019) focused directly on frameworks for measuring SME innovation impact within R&D tax credit and incentive schemes across EU member states.
INVENTYA VENTURES (EU) LIMITED
Irish innovation consultancy SME with expertise in R&D tax analytics, SME benchmarking, and applied behavioral biosignal research.
Their core work
Inventya Ventures is a Dublin-based innovation consultancy SME that operates at the intersection of R&D funding intelligence and applied behavioral technology research. In their WATSON project, they contributed to building ICT-based frameworks for evaluating SME innovation policy within R&D tax credit and incentive schemes — work that requires practical knowledge of how companies access and report on public funding. Their participation in POTION, a multidisciplinary project studying emotional body odours and social interaction, introduced them to a radically different domain involving wearable biosignal systems, virtual reality, and chemical analysis for mental health applications. This unusual combination points to an organization that positions itself as a flexible specialist partner capable of bridging business intelligence and emerging research technologies.
What they specialise in
WATSON involved SME segmentation, benchmarking, and analytics tooling delivered through an ICT platform, suggesting hands-on capability in structuring and processing innovation funding data.
WATSON included an ICT platform component for policy support, indicating software or data platform delivery as part of their contribution.
Participation in POTION (2019–2024) brought involvement in wearable biosignal processing, virtual reality, and chemosignal research targeting mental health and social interaction.
How they've shifted over time
In their first H2020 project (2017–2019), Inventya Ventures was firmly positioned in the innovation policy and funding analytics space — working on R&D tax credits, SME segmentation, benchmarking indicators, and ICT platforms to support innovation policymakers and business intermediaries. By 2019 they had entered a completely different domain through POTION: human chemosignals, virtual reality environments, wearable biosignal systems, and mental health applications. This is not an incremental pivot — it is a thematic leap across disciplines, which either reflects deliberate portfolio diversification or their function as a business/dissemination partner within a larger scientific consortium they did not lead.
Their trajectory suggests a move away from pure innovation consultancy toward participation in deep-tech and applied behavioral science consortia, though with only two projects it is too early to call this a confirmed strategic direction.
How they like to work
Inventya Ventures has exclusively joined projects as a participant, never leading a consortium as coordinator — consistent with the profile of a specialist SME that contributes defined expertise to larger collaborative initiatives. Their two projects engaged 14 distinct partners across 9 countries, suggesting they are comfortable operating in broad, multi-national consortia rather than tight bilateral arrangements. The sharp thematic contrast between their two projects implies flexibility in whom they partner with, potentially taking on different roles — business intelligence provider in WATSON and a more applied technical or dissemination role in POTION.
Inventya Ventures has built connections with 14 unique consortium partners spanning 9 countries through just two projects, indicating decent network density relative to their small project portfolio. Their geographic reach is pan-European, though no specific country clustering is discernible from this limited dataset.
What sets them apart
Inventya Ventures is an Irish innovation SME with an unusual dual footprint: practical expertise in R&D funding policy and SME benchmarking on one hand, and participation in frontier behavioral science research on the other. For consortium builders, this means they can credibly contribute both business-facing analytics and applied research roles — a versatility rare in organizations of their size. However, their limited project track record (2 projects, no coordination experience) means they are best evaluated as a support partner rather than a consortium anchor.
Highlights from their portfolio
- POTIONThe largest funding award (EUR 426,625) and longest duration (2019–2024) of the two projects, covering an unusually interdisciplinary scope — emotional chemosignals, VR, wearables, and mental health — within a Research Excellence framework.
- WATSONDirectly aligned with Inventya's core consultancy identity, this project built an ICT-based methodology for evaluating SME innovation policy across R&D tax incentive schemes, a topic with direct commercial relevance to their client base.